Last reviewed · How we verify
Skin Repairing Cream
A topical formulation designed to repair and restore skin barrier function and promote tissue healing.
A topical formulation designed to repair and restore skin barrier function and promote tissue healing. Used for Skin repair and restoration (Phase 3 indication not fully specified in public domain).
At a glance
| Generic name | Skin Repairing Cream |
|---|---|
| Sponsor | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | Phase 3 |
Mechanism of action
Skin Repairing Cream is a dermatological product intended to enhance skin repair processes, likely through moisturization, barrier restoration, and promotion of natural healing mechanisms. The exact active ingredients and molecular targets are not publicly detailed, but such creams typically work by reducing transepidermal water loss, supporting keratinocyte function, and facilitating wound healing or skin recovery.
Approved indications
- Skin repair and restoration (Phase 3 indication not fully specified in public domain)
Common side effects
Key clinical trials
- Endocare Repair Efficacy Skincare Products in the Use of Post-laser Treatment (NA)
- Evaluation of Hydrating Cream Effect on Subjects With Dry Skin. (NA)
- Treatment of Basal Cell Carcinoma (BCC) of the Skin, of the Morpheiform, Infiltrative, and Noduloulcerative Types in Inoperable Patients and Not Suitable for Radiotherapy Using Formulated Methylene Blue (PHASE3)
- Investigation of Effect of Formulated Methylene Blue on Treatment of Squamous Cell Carcinoma Skin Cancer in Inoperable Patients and Not Suitable for Radiotherapy (PHASE3)
- A Clinical Trial to Investigate the Efficacy and Safety of GenLabs' Social Skin on Improving Acne Symptoms and Skin Repair Among Healthy Adults (NA)
- Targeting the Mechanisms Underlying Cutaneous Neurofibroma Formation in NF1: A Clinical Translational Approach.
- Use of Progenitor Biological Bandages in Burn Care (Bru_PBB) (PHASE1, PHASE2)
- Modulating the Skin Microbiome to Prevent Radiation Dermatitis in Breast Cancer (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Skin Repairing Cream CI brief — competitive landscape report
- Skin Repairing Cream updates RSS · CI watch RSS
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University portfolio CI